| Literature DB >> 36131162 |
Elisabeth C McLemore1,2, Lawrence Lee3, Traci L Hedrick4, Laila Rashidi5, Erik P Askenasy6, Daniel Popowich7, Patricia Sylla8.
Abstract
BACKGROUND: As enhanced recovery programs (ERPs) have continued to evolve, the length of hospitalization (LOS) following elective minimally invasive colorectal surgery has continued to decline. Further refinements in multimodal perioperative pain management strategies have resulted in reduced opioid consumption. The interest in ambulatory colectomy has dramatically accelerated during the COVID-19 pandemic. Severe restrictions in hospital capacity and fear of COVID transmission forced surgical teams to rethink strategies to further reduce length of inpatient stay.Entities:
Keywords: Ambulatory colectomy; Colectomy; Enhanced recovery after surgery; Enhanced recovery program; Enhanced recovery protocols; Minimally invasive surgery; Same day colectomy; Same day discharge
Year: 2022 PMID: 36131162 PMCID: PMC9491699 DOI: 10.1007/s00464-022-09606-y
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 3.453
Benefits of ERPs in colorectal surgery
| Downsides of hospitalization following surgery | Benefits of implementation of basic ERPs |
|---|---|
| • Hospital acquired infections/exposure risks | • Earlier return of gi function |
| • Non-compliance of nursing staff and allied health care professionals with early and sustained ambulation and out of bed programs | • Reduced length of hospital stay |
| • Increased narcotic usage and prescribing | • Reduced deconditioning |
| • Earlier return to work | |
| • Earlier initiation of systemic chemotherapy for patients with colorectal cancer (which is associated with better cancer outcomes) | |
| • Higher patient satisfaction | |
| • Reduced health care utilization and costs | |
| • Multidisciplinary teamwork to align health care delivery in all phases of preparation, education, admission, surgery, anesthesia, multi-modal pain management, and recovery | |
| • Reduced re-admission rates | |
| • Improved perioperative patient education | |
| • Reduced variability in care | |
| • Surgical culture evolution |
The SAGES colorectal surgery committee has identified three key areas to help further evolve erps and establish prior to SDD implementation
| SDD protocol “KEY THREE” |
|---|
| (1) Assessing discharge readiness prior to return of gastrointestinal function |
| (a) I-FEED score |
| (b) Early mobilization and initiation of oral electrolyte beverages in the post operative recovery area |
| (2) Reducing postoperative pain improves efficacy of oral analgesia post-operatively |
| (a) Multi-modal, opioid sparing pain management |
| (b) Intra-operative use of opioid sparing drips such as dexmedetomidine hydrochloride, lidocaine, ketamine, propofol |
| (c) TAPP blocks, rectus sheath blocks |
| (d) Less painful specimen extraction incision locations (ex. Pfannenstiel) |
| (3) Established post-discharge remote monitoring plan |
| (a) Apps, telephone visits, video visits |
Fig. 1“The I-FEED scoring system was created out of the need for a consistent objective definition of impaired postoperative GI function”. I intake, F feeling nauseated, E emesis, E exam, D duration of symptoms [22]
Factors associated with discharge the same date as operation in the University of Texas Health SDD enhanced recovery program (unpublished data)
| Perioperative factors | % SDD | ||
|---|---|---|---|
| Patient factors | |||
| Male sex | 78.4 | 37 | |
| Female sex | 61.4 | 44 | |
| Age 65 or younger | 75.0 | 44 | |
| Above age 65 | 62.2 | 37 | |
| Previous abdominal surgery | 66.7 | 45 | |
| No previous abdominal surgery | 72.2 | 36 | |
| On anticoagulation | 66.7 | 6 | |
| No anticoagulation (excluding low dose aspirin) | 64.2 | 75 | |
| BMI < 25 | 64.3 | 14 | |
| BMI > 25 | 65.5 | 29 | |
| BMI > 30 | 71.4 | 21 | |
| BMI > 35 | 76.5 | 17 | |
| Presence of DM | 45.5 | 11 | |
| Absence of DM | 72.9 | 70 | |
| Case factors | |||
| Incision after 9 AM | 72.0 | 25 | |
| Incision before 9 AM | 67.9 | 56 | |
| Finished before 12 PM | 80.5 | 41 | |
| Finish after 12 PM | 58.3 | 24 | |
| Finished after 1 PM | 56.3 | 16 | |
| Blood loss < 50 mL | 77.1 | 61 | |
| Blood loss > 50 mL | 45.0 | 20 | |
| Total IVF < 1 L | 86.2 | 29 | |
| Total IVF > 1 L | 59.6 | 52 | |
| Operative duration < 180 min | 85.0 | 40 | |
| Operative duration < 180 min | 53.7 | 41 | |
| ASA 2 | 74.2 | 31 | |
| ASA 3 | 67.4 | 49 | |
| Wound class 2 | 70.4 | 71 | |
| Wound class 3 | 50.0 | 2 | |
| Wound class 4 | 62.5 | 8 | |
| Right colectomy | 66.7 | 30 | |
| Left/sigmoid/LAR colectomy | 74.5 | 47 | |
| Malignant indication | 66.7 | 36 | |
| Benign indication | 71.1 | 45 | |
| Any narcotics (including operation) | 56.8 | 37 | |
| No narcotics (including operation) | 79.6 | 44 | |
| Hydromorphone 0.6 mg or less | 77.2 | 57 | |
| Greater than hydromorphone 0.6 mg | 50.0 | 24 | |
Bold indicate statistically significant p values (p < 0.05)
Comparison of SDD protocol outcomes between the original french study by Gignoux et al., McGill, Kaiser Permanente LAMC, MultiCare Tacoma General Hospital, and UT Health experience
| Chasseranta ( | Leeb ( | McLemorec ( | Rashidid ( | Askenasye ( | |
|---|---|---|---|---|---|
| Mean age | 59.1 (SD 11.4) | 58.7 (SD 12.8) | 55.6 (SD 14.0) | 57.0 (SD 13.7) | 61.0 (SD 13.8) |
| Male sex | 55% | 52% | 40.5% | 41.7% | 45.7% |
| BMI | 26.5 (SD 5.1) | 26.5 (SD 5.6) | 28.2 (SD 5.9) | 30 (SD 5.8) | 30.6 (SD 6.5) |
| Indication for surgery | |||||
| Neoplasm | 34% | 53% | 57% | 59% | 60% |
| Diverticular disease | 62% | 4% | 14% | 24% | 37% |
| IBD | 0% | 4% | 0% | 6% | 2% |
| Stoma | 0% | 33% | 27% | 0% | 0% |
| Other | 3% | 7% | 2% | 11% | 1% |
| MIS procedure type | |||||
| Left/sigmoid | 85% | 26% | 25% | 8% | 36% |
| Right/transverse | 14% | 25% | 27% | 24% | 38% |
| Total colectomy | 1% | 0% | 0% | 0% | 0% |
| LAR | 0% | 16% | 17% | 52% | 26% |
| Stoma closure | 0% | 33% | 31% | 0% | 0% |
| Other | 0% | 0% | 0% | 16% | 0% |
| Discharged on POD 0 | 93% | 84% | 70% | 62% | 69% |
| 30-day unscheduled evaluation | 21% | 14% | 14% | 12% | 16% |
| 30-day readmission | 6% | 11% | 13.5% | 0.8% | 9.9% |
| Anastomotic leak | 3 (1.9%) | 4 (3.5%) | 1 (2.7%) | 0 | 3 (3.7%) |
| Re-operation | 6 (3.8%) | 3 (2.6%) | 1 (2.7%) | 0 | 3 (3.7%) |
aGignoux et al.
bMcGill
cKaiser Permanente LAMC
dMultiCare Tacoma General Hospital
eUT Health
“Healthy patient, healthy anastomosis” patient and case selection factors for SDD [43, 44, 48, 51]
| Patient selection factors | Case selection factors |
|---|---|
| Patient inclusion criteria | Case inclusion criteria |
| • Adult | • Elective surgery |
| • Hgb > 10 | • Minimally invasive surgery |
| • Albumin > 3.5, pre-albumin > 20 | • Off midline specimen extraction site: examples: pffanensteil extraction incision, natural orifice extraction, ostomy site extraction |
| • Ambulatory | |
| • Functionally independent | |
| • No contraindications to TAP block (incl. allergies to dexamethasone or bupivacaine) or opioid-sparing analgesia (i.e. NSAIDs or acetaminophen) | |
| • Adequate home support | |
| • Owns and is capable of using a telephone or ‘smart’ mobile device running iOS or Android (or other device needed for remote monitoring) | |
| Patient exclusion criteria | Case exclusion criteria |
| • Cognitive impairment | • Intraoperative complications |
| • Significant cardiopulmonary disease | • Prolonged operative time |
| • Anemia (Hgb < 10) | • More than one bowel anastomosis created |
| • Malnutrition (albumin < 3.5) | • Any revisions needed for the initial anastomosis |
| • Active tobacco/nicotine use | • Excessive intra-operative bleeding/transfusion |
| • Coronary artery disease | • Creation of new ostomy |
| • Cardiac arrhythmia | • Locally advanced malignancy requiring multi-visceral resection |
| • Chronic anticoagulation or coagulopathy | |
| • Liver or renal failure | |
| • Chronic opioid use | |
| • Inflammatory bowel disease (crohns disease, ulcerative colitis) | |
| • Home > 1 h travel from institution | |
| • Lack of adequate home support | |
| • Language barrier (primary language other than patient education instructions) | |
| • Unable to participate in remote monitoring: no telephone, or no ‘smart’ mobile device |
Comparison of outcomes of SDD vs. ERP with 3-day target length of stay; both cohorts had post-discharge remote follow-up with a mHealth phone app [43]
| Same day discharge ( | Standard ERP ( | ||
|---|---|---|---|
| Mean age, years (SD) | 60.2 (10.5) | 56.5 (13.1) | 0.111 |
| Male gender | 22 (46%) | 43 (59%) | 0.158 |
| Body mass index, kg/m2 (SD) | 26.3 (5.0) | 27.7 (5.3) | 0.171 |
| ASA physical status | 0.499 | ||
| 1 | 4 (8%) | 4 (5%) | |
| 2 | 27 (55%) | 38 (52%) | |
| 3 + | 17 (35%) | 31 (43%) | |
| Indication for surgery | 0.027 | ||
| Neoplasm | 25 (52%) | 47 (64%) | |
| Inflammatory bowel disease | 3 (6%) | 12 (16%) | |
| Stoma closure | 15 (31%) | 7 (10%) | |
| Diverticular disease | 2 (4%) | 4 (5%) | |
| Other | 3 (6%) | 3 (4%) | |
| Procedure performed | 0.022 | ||
| Right colectomy | 14 (29%) | 33 (45%) | |
| Left/sigmoid colectomy | 12 (25%) | 22 (30%) | |
| Low anterior resection | 7 (15%) | 11 (15%) | |
| Stoma closure | 15 (31%) | 7 (10%) | |
| Mean procedure time, min (SD) | 116 (56) | 177 (74) | < 0.001 |
| Median estimated blood loss, mL [IQR] | 5 [5–100] | 100 [28–200] | 0.089 |
| Mean PACU time, min (SD) | 311 (242) | 260 (216) | 0.242 |
| Median length of stay, days [IQR] | 0 [0–0] | 2 [1-4] | < 0.001 |
| 30-day complications | 8 (17%) | 11 (15%) | 0.813 |
| 30-day ED visit | 5 (10%) | 6 (8%) | 0.664 |
| 30-day readmission | 3 (6%) | 3 (4%) | 0.681 |
Fig. 2McGill SDD selection pathway, February 2020 to January 2022 [44]
Fig. 3SDD home recovery trends of pain score (red), oxycodone 5 mg tablet use (green), and I-FEED score (blue) in the first 7 days after surgery. Data was obtained during the daily telephone remote visits on POD 1–7. Despite initially high pain scores on POD 1 and 2, patient opioid use was low with a mean number of five tablets used per patient during the entire postoperative recovery [48] (Color figure onlne)
Standard ERPs vs. SDD for MIS CRS
| Standard ERPs for elective colorectal surgery | SDD for elective colorectal surgery |
|---|---|
| Patient and family/social support education | Extensive patient and family/social support education |
| • Setting up expectations for early ambulation, multi-modal pain management, hospital length of stay | • Setting up expectations for early ambulation, multi-modal pain management, hospital length of stay |
| • Social support at home | |
| • Distance from hospital assessment | |
| • Plan ahead/worst case scenario: don’t delay, and return to same hospital/emergency department as surgery location if problems or complications arise | |
| • Set up remote monitoring plan (phone, video, or app remote monitoring) | |
| • Provide contact information for Surgical Department, Hospital, etc. for urgent questions or issues | |
| Preoperative optimization & pre-habilitation | Preoperative optimization |
| • Weight loss (Ideal BMI 30) if possible | • Weight loss (Ideal BMI 30) if possible |
| • Exercise/conditioning 20 min daily sustained activity (in ambulatory patients) | • Exercise/conditioning 20 min daily sustained activity (in ambulatory patients) |
| Preoperative nutritional assessment | Preoperative nutritional assessment |
| • Alternatives to anastomosis planning for sub-optimal nutrition levels | • If low nutritional levels, not an ideal candidate for SDD ERAS (Alb < 3.5 or Pre-albumin < 21) |
| • If NEW ostomy (temporary or permanent needed), not an ideal candidate for SDD ERAS | |
| Management of anemia | Management of anemia |
| • Alternatives to anastomosis planning for sub-optimal Hgb/Hct levels vs. pre-operative correction of anemia (IV Iron, pRBC Transfusion, etc.) | • Anemia is a contra-indication for SDD Note: If low Hgb/Hct (< 10/ < 30), this is a contra-indication for SDD |
| ± Bowel preparation | ± Bowel preparation |
| Electrolyte therapy/hydration | Electrolyte therapy/hydration |
| Decreased fasting | Decreased fasting |
| Antimicrobial prophylaxis and skin preparation | Antimicrobial prophylaxis and skin preparation |
| Dietary supplementation (Immunotherapy drinks) | Dietary supplementation (Immunotherapy drinks) |
| Day of surgery preparations and pre-op anesthesia | |
| Dietary supplementation (Immunotherapy drinks) | Dietary supplementation (Immunotherapy drinks) |
| Decreased fasting | Decreased fasting |
| Pre-operative warming | Pre-operative warming |
| Maintain normal glycemic levels | Maintain normal glycemic levels |
| Thromboprophylaxis | Thromboprophylaxis |
| ± Alvimopan | ± Alvimopan |
| Pre-operative patient/family/support re-education | |
| • Early ambulation after surgery (sitting in chair, then walking) | |
| • Multi-modal analgesia plan | |
| • Patient check In–solicit their intent to proceed with SDD vs. standard of care post operative hospitalization | |
| Minimize intra-operative fluids/hemodynamic goal directed therapy | Minimize intra-operative fluids/hemodynamic goal directed therapy |
| • 500–700 mL maximal IVF goal | |
| • Approximately 3 mL/kg/h for an average 70 kg patient | |
| Surgical approach | Surgical approach |
| • Minimally invasive surgery | • Minimally invasive surgery |
| • Less painful specimen extraction site: natural orifice, pfannenstiel | |
| • Intra-corporeal anastomosis | |
| Avoid nasogastric tubes and unnecessary drains | Avoid nasogastric tubes and unnecessary drains |
| Prevent intraoperative hypothermia | Prevent intraoperative hypothermia |
| Maintain normal glycemic levels | Maintain normal glycemic levels |
| Analgesia/anesthesia | Analgesia/anesthesia |
| • Multimodal anesthesia | • Multimodal anesthesia |
| • Narcotic sparing approach | • Narcotic sparing approach |
| • ± Epidural–only recommended in open cases | • Abdominal wall blocks (TAP/rectus sheath) |
| • ± Spinal anesthesia for MIS cases | • Propofol, lidocaine, dexmedotomidine, ketamine hydrochloride infusions |
| • Abdominal wall blocks (TAP/Rectus Sheath) | • Bispectral index (BIS™) monitoring |
| • ± Posteromedial quadratus lumborum (QL) block Note: Epidural/spinal blocks not recommended for SDD programs at this time due to potential for urinary retention, vasovagal responses, and need for hospital monitoring | |
| Postoperative fluid and electrolyte therapy (avoid over resuscitation) | Postoperative fluid and electrolyte therapy (avoid over resuscitation) |
| Prevention of postoperative ileus | Prevention of postoperative ileus |
| • Limited opioid use/focus on short acting opioids | • Limited opioid use/focus on short acting opioids |
| • Multimodal analgesia therapy | • Multimodal analgesia therapy |
| • Avoiding routine NGT | • Avoiding routine NGT |
| • Maintaining fluid balance | • Maintaining fluid balance |
| • Alviompan (if given pre-op) | • Alvimopan (2nd and last dose; if given pre-op) |
| • ± Chewing gum, magnesium oxide | |
| • Early out of bed to chair (within 1 h of PACU arrival) | |
| Post-operative glycemic control | Post-operative glycemic control |
| Post-operative nutritional care | Post-operative nutritional care |
| • Offer clear liquids immediately (typically does not occur until Med/Surg hospital admission) | • Offer electrolyte clear liquids immediately In PACU (once sitting in chair) |
| Post-operative ambulation | Post-operative mobilization and ambulation |
| • Encourage early ambulation | • Early out of bed to chair (within 1 h of PACU arrival) |
| • Ambulation once full level of alertness achieved | |
| • ± Visit with physical therapist in PACU per hospital/PACU staffing and availability | |
| Post-operative deep breath teaching | Post-operative deep breath teaching |
| • Incentive spirometer education In PACU | |
| Urinary drainage | Urinary drainage |
| • Foley removal POD 0–1 in colon surgery | • Avoid routine foley in colon surgery or anterior resection Note: LAR/APR patients with diverting loop ileostomy are not considered candidates for SDD ERAS (ostomy teaching/high output ileostomy management and prevention, etc.) |
| • Foley removal POD 2–3 in rectal surgery | |
| Full recovery from anesthesia | Full recovery from anesthesia |
| Tolerating liquids or solids without nausea or vomiting | Tolerating liquids without nausea or vomiting |
| • I-FEED score: 0–1 | |
| • Early/immediate anesthesia emergence nausea and vomiting with resolution is acceptable, so long as I-FEED score is 0–1 prior to discharge | |
| Absence of clinical findings suspicious for infection or bleeding | n/a |
| ± Flatus/BM | n/a |
| Voiding independently | Voiding independently |
| Discharge instructions | Discharge instructions |
| Wound care, diet, after hours contact information, regular business office hours contact information, post operative visit(s) scheduled, pain management reviewed, when to call/what to be concerned about during recovery | Wound care, diet, after hours contact information, regular business office hours contact information, post operative visit(s) scheduled, pain management reviewed, when to call/what to be concerned about during recovery |
| • Review and confirm social support at home | |
| • Distance from hospital re-assessment | |
| • Worst case scenario action plans: don’t delay, and return to same hospital/emergency department as surgery location if problems or complications arise | |
| Review and confirm remote monitoring plan is in place (phone, video, or app remote monitoring) | |